Fatal influenza B infections: Time to reexamine influenza research priorities

Journal of Infectious Diseases

Volumn 205, Issue 6, 2012, Pages 870-872

  McCullers, Jonathan A ^a   Hayden, Frederick G ^b,c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS ANTIGEN;

BACTERIAL PNEUMONIA; BACTERIAL SUPERINFECTION; CARDITIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; FATALITY; HIGH RISK POPULATION; HUMAN; IMMUNOCOMPETENCE; INFECTION RISK; INFLUENZA A (H5N1); INFLUENZA B; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS B; MEDICAL RESEARCH; MORTALITY; NONHUMAN; NOTE; PANDEMIC INFLUENZA; PRIORITY JOURNAL; RESEARCH PRIORITY; RISK FACTOR; SEASONAL INFLUENZA; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS NEUTRALIZATION;

FEMALE; HEART INJURIES; HUMANS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MALE; MYOCARDIUM; PNEUMONIA, BACTERIAL;

EID: 84857565223     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir865     Document Type: Note

References (19)

1. Fleming DM, Elliot AJ. Lessons from 40 years' surveillance of influenza in England and Wales. Epidemiol Infect 2008;136:866-75.
2. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998;178:53-60.
3. Collins SD, Lehmann J. Trends and epidemics of influenza and pneumonia: 1918-1951. Public Health Rep 1951;66:1487-516.
4. Osterhaus AD, Rimmelzwaan GF, Martina BE, Bestebroer TM, Fouchier RA. Influenza B virus in seals. Science 2000;288:1051-3.
5. Centers for Disease Control. Influenza associated pediatric deaths-United States, September 2010-August 2011. MMWR Morb Mortal Wkly Rep 2011;60:1233-8.
6. Mauad T, Hajjar LA, Callegari GD, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med 2010;181:72-9.
7. Gill JR, Sheng ZM, Ely SF, et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med 2010;134:235-43.
8. Wanzeck K, Boyd KL, McCullers JA. Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice. Am J Respir Crit Care Med 2010;183:767-73.
9. Paddock CD, Liu L, Denison AM, et al. Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection. J Infect Dis 2012;205:895-905.
10. Finelli L, Fiore A, Dhara R, et al. Influenza associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 2008;122:805-11.
11. Iverson AR, Boyd KL, McAuley JL, Plano LR, Hart ME, McCullers JA. Influenza virus primes mice for pneumonia from Staphylococcus aureus. J Infect Dis 2011;203:880-8.
12. Hers J F P, Masurel N, Mulder J. Bacteriology and histopathology of the respiratory tract and lungs of fatal Asian influenza. Lancet 1958;2:1164-5.
13. Finland M, Parker F, Barnes MW, Joliffe LS. Acute myocarditis in influenza A infections. Two cases of non-bacterial myocarditis, with isolation of virus from the lungs. Am J Med Sci 1945;209:455-68.
14. Ison MG, Campbell V, Rembold C, Dent J, Hayden FG. Cardiac findings during uncomplicated acute influenza in ambulatory adults. Clin Infect Dis 2005;40:415-22.
15. Ukimura A, Izumi T, Matsumori A. A national survey on myocarditis associated with the 2009 influenza A (H1N1) pandemic in Japan. Circ J 2010;74:2193-9.
16. Weiss TW, Stensaeth KH, Eritsland J. Myocarditis in a juvenile patient with influenza A virus infection. Eur Heart J 2010;31:277.
17. Ray CG, Icenogle TB, Minnich LL, Copeland JG, Grogan TM. The use of intravenous ribavirin to treat influenza virus-associated acute myocarditis. J Infect Dis 1989;159:829-36.
18. Hien TT, Ruiz-Palacios G, Hayden FG, Farrar J. Patient-oriented pandemic influenza research. Lancet 2009;373:2085-6.
19. The In FACT Global H1N1 Collaboration. In FACT: a global critical care research response to H1N1. Lancet 2010;375:11-13.